722 related articles for article (PubMed ID: 27372564)
1. Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization.
Pesce S; Greppi M; Tabellini G; Rampinelli F; Parolini S; Olive D; Moretta L; Moretta A; Marcenaro E
J Allergy Clin Immunol; 2017 Jan; 139(1):335-346.e3. PubMed ID: 27372564
[TBL] [Abstract][Full Text] [Related]
2. Increased Frequency of Dysfunctional Siglec-7
Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
Front Immunol; 2021; 12():603133. PubMed ID: 33692781
[TBL] [Abstract][Full Text] [Related]
3. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1.
Greppi M; Obino V; Goda R; Rebaudi F; Carlomagno S; Della Chiesa M; Sivori S; Ubezio G; Agostini V; Bo A; Pesce S; Marcenaro E
Front Immunol; 2023; 14():1183215. PubMed ID: 37441071
[TBL] [Abstract][Full Text] [Related]
5. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers.
Liu Y; Cheng Y; Xu Y; Wang Z; Du X; Li C; Peng J; Gao L; Liang X; Ma C
Oncogene; 2017 Nov; 36(44):6143-6153. PubMed ID: 28692048
[TBL] [Abstract][Full Text] [Related]
7. Features of Memory-Like and PD-1(+) Human NK Cell Subsets.
Della Chiesa M; Pesce S; Muccio L; Carlomagno S; Sivori S; Moretta A; Marcenaro E
Front Immunol; 2016; 7():351. PubMed ID: 27683578
[TBL] [Abstract][Full Text] [Related]
8. PD-1 blocks lytic granule polarization with concomitant impairment of integrin outside-in signaling in the natural killer cell immunological synapse.
Huang Y; Chen Z; Jang JH; Baig MS; Bertolet G; Schroeder C; Huang S; Hu Q; Zhao Y; Lewis DE; Qin L; Zhu MX; Liu D
J Allergy Clin Immunol; 2018 Oct; 142(4):1311-1321.e8. PubMed ID: 29679656
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cells.
Quatrini L; Vacca P; Tumino N; Besi F; Di Pace AL; Scordamaglia F; Martini S; Munari E; Mingari MC; Ugolini S; Moretta L
J Allergy Clin Immunol; 2021 Jan; 147(1):349-360. PubMed ID: 32417134
[TBL] [Abstract][Full Text] [Related]
11. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.
Beldi-Ferchiou A; Lambert M; Dogniaux S; Vély F; Vivier E; Olive D; Dupuy S; Levasseur F; Zucman D; Lebbé C; Sène D; Hivroz C; Caillat-Zucman S
Oncotarget; 2016 Nov; 7(45):72961-72977. PubMed ID: 27662664
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subset.
Chieregato K; Zanon C; Castegnaro S; Bernardi M; Amati E; Sella S; Rodeghiero F; Astori G
Blood Transfus; 2017 Jan; 15(1):93-100. PubMed ID: 27136441
[TBL] [Abstract][Full Text] [Related]
13. Human CD56
Amand M; Iserentant G; Poli A; Sleiman M; Fievez V; Sanchez IP; Sauvageot N; Michel T; Aouali N; Janji B; Trujillo-Vargas CM; Seguin-Devaux C; Zimmer J
Front Immunol; 2017; 8():699. PubMed ID: 28674534
[TBL] [Abstract][Full Text] [Related]
14. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
[TBL] [Abstract][Full Text] [Related]
15. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Huth TK; Staines D; Marshall-Gradisnik S
J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
[TBL] [Abstract][Full Text] [Related]
16. [Expression and function of killer immunologublin receptor and CD57 of natural killer cells].
Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 46(1):115-9. PubMed ID: 24535362
[TBL] [Abstract][Full Text] [Related]
17. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
18. An Uncoupling of Canonical Phenotypic Markers and Functional Potency of
Lieberman NAP; DeGolier K; Haberthur K; Chinn H; Moyes KW; Bouchlaka MN; Walker KL; Capitini CM; Crane CA
Front Immunol; 2018; 9():150. PubMed ID: 29456538
[TBL] [Abstract][Full Text] [Related]
19. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
20. Immunosenescence of human natural killer cells.
Gayoso I; Sanchez-Correa B; Campos C; Alonso C; Pera A; Casado JG; Morgado S; Tarazona R; Solana R
J Innate Immun; 2011; 3(4):337-43. PubMed ID: 21576928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
